dihexa cas API | 1401708-83-5 Manufacturer & Supplier in China Dihexa Powder CAS 1401708-83-5 Chemical

Bio Mater

GLP-1 combination therapy Researched alongside GLP-1 agonists like semaglutide (CagriSema) in investigational obesity trials, still under study

Promotes Collagen Synthesis Studies show BPC-157 enhances growth hormone receptor expression in tendon fibroblasts, leading to increased collagen production

Other assessments included changes in laboratory parameters (including but not limited to haematology and biochemistry), and physical examination, vital signs and ECG

Regulatory status: unapproved and research-use-only As of the preparation of this article, BPC-157 has not received marketing authorization from the US Food and Drug Administration, the European Medicines Agency, or equivalent national regulators for any therapeutic indication

Its simultaneous activity at three incretin-related receptors makes it a useful tool compound for probing combined signalling pathways in metabolic research